Notes
J . Org. Chem., Vol. 62, No. 16, 1997 5625
with ether (3 × 5 mL). The combined organic layers were dried
(Na2SO4) and concentrated at reduced pressure. Hydroxylamine
3a was obtained as a yellow oil (420 mg, 94%) after purifica-
tion using flash chromatography (cyclohexane:ethyl acetate
95/5). 3a : 1H NMR (CDCl3) δ 2.36 (dt, J ) 7.6/14.3 Hz, 1H),
2.52 (dt, J ) 6.0/14.3 Hz, 1H), 3.07 (ddt, J ) 4.2/6.0/7.6 Hz, 1H),
3.63 (dd, J ) 4.2/10.1 Hz, 1H), 3.78 (dd, J ) 6.0/10.1 Hz, 1H),
3.97 (s, 2H), 4.54 (s, 2H), 5.03-5.12 (m, 2H), 5.19 (br s, 1H),
5.86 (ddt, J ) 6.0/7.6/13.8 Hz, 1H), 7.28-7.40 (m, 10H); 13C
NMR (CDCl3) δ 32.8, 60.7, 64.9, 69.4, 73.2, 116.5, 127.1, 127.6,
dry CH2Cl2 (5 mL), and the reaction mixture was stirred at rt
overnight. Hexane (2 mL) was added, and the solution was
filtered (Celite) and evaporated under reduced pressure to afford
silylated hydroxylamine (442 mg, 86%) as a dense oil.11 The
product was dissolved in CHCl3 (5 mL), the solution was cooled
at 0 °C, and NIS (540 mg, 2.4 mmol) was added. After being
stirred in the dark for 2 h at 0 °C, the reaction was quenched
with aqueous Na2S2O3, and the aqueous layer was extracted with
CHCl3 (3 × 5 mL). cis-4a (208 mg, 41%) and trans-4a (254 mg,
50%) were separated using flash chromatography eluting with
cyclohexane/ethyl acetate 95:5. 3,5-cis-4a : oil; 1H NMR (CDCl3)
δ 1.92 (dt, J ) 6.2/12.7 Hz, 1H), 2.66 (dt, J ) 7.9/12.7 Hz, 1H),
3.13 (dd, J ) 8.4/9.6 Hz, 1H), 3.29 (dd, J ) 5.0/9.6 Hz, 1H), 3.29-
3.38 (m, 1H), 3.49 (dd, J ) 5.8/9.6 Hz, 1H), 3.57 (dd, J ) 6.9/9.6
Hz, 1H), 3.99 (d, J ) 13.8 Hz, 1H), 4.12 (d, J ) 13.8 Hz, 1H),
4.39 (m, 1H), 4.49 (d, J ) 12.0 Hz, 1H), 4.55 (d, J ) 12.0 Hz,
1H), 7.22-7.40 (m, 10H); 13C NMR (CDCl3) δ 8.1, 38.3, 61.5, 65.0,
71.8, 73.3, 76.6, 127.2, 127.7, 128.2, 128.4, 128.8, 136.2, 139.8.
Anal. Calcd for C19H22NO2I: C, 53.89; H, 5.24; N, 3.31.
128.2, 128.4, 129.2, 136.0, 138.2, 138.4. Anal. Calcd for C19H23
-
NO2: C, 76.72; H, 7.80; N, 4.71. Found: C, 76.92; H, 7.75; N,
4.83.
Meth od B (Ta ble 1, En tr y 4). Nitrone (383 mg, 1.5 mmol)
and DEAC (∼1.8 M in hexane, 0.82 mL) in THF (2 mL) were
equilibrated at -40 °C for 20 min. At the same temperature, a
solution of crotylzinc bromide (6 mL, 0.5 M, 3 mmol) was added,
and the reaction mixture was stirred for 1.5 h.
Meth od C (Ta ble 1, En tr y 5). A solution of crotylzinc
bromide (5 mL, 0.16 M, 0.8 mmol) was treated with DEAC (0.21
mL, 0.8 mmol) at -40 °C for 30 min. Solid nitrone (100 mg,
0.39 mmol) was added at -40 °C, and stirring was continued
for 1.5 h.
N-Hyd r oxy-N-ben zyl-1-(ben zyloxy)-3-m eth yl-4-p en ten -
2-a m in e (3b). The product was obtained as a solid mixture of
the two syn/ anti isomers having the same Rf on silica gel. The
following spectroscopic data were drawn from the enriched
mixtures obtained in entries 3 and 4 of Table 1. syn-3b: 1H
NMR (CDCl3) δ 1.17 (d, J ) 6.8 Hz, 3H), 2.54-2.67 (m, 1H),
2.82 (ddd, J ) 3.0/5.8/8.7 Hz, 1H), 3.75 (dd, J ) 3.0/10.2 Hz,
1H), 3.87 (dd, J ) 5.8/10.2 Hz, 1H), 3.92 (d, J ) 13.7 Hz, 1H),
4.16 (d, J ) 13.7 Hz, 1H), 4.53 (s, 2H), 4.99 (ddd, J ) 0.7/1.9/
10.2, 1H), 5.05 (ddd, J ) 1.0/1.9/17.2, 1H), 5.32 (br s, 1H), 5.79
(ddd, J ) 8.3/10.2/17.2 Hz, 1H), 7.20-7.42 (m, 10H); 13C NMR
(CDCl3) δ 18.1, 38.8, 61.3, 68.9, 73.4, 80.9, 114.5, 127.1, 127.7,
128.3, 128.4, 128.7, 130.3, 135.7, 139.1, 141.8. anti-3b: 1H NMR
(CDCl3) δ 1.08 (d, J ) 6.8 Hz, 3H), 2.52-2.67 (m, 1H), 2.89 (ddd,
J ) 3.2/5.7/7.4 Hz, 1H), 3.73 (dd, J ) 3.2/10.2 Hz, 1H), 3.78 (dd,
J ) 5.7/10.2 Hz, 1H), 3.88 (d, J ) 13.9 Hz, 1H), 4.15 (d, J )
13.9 Hz, 1H), 4.56 (s, 2H), 5.00-5.07 (m, 2H), 5.39 (br s, 1H),
5.97 (ddd, J ) 7.7/10.3/17.1 Hz, 1H), 7.21-7.38 (m, 10H); 13C
NMR (CDCl3) δ 17.4, 38.4, 60.6, 67.1, 69.6, 73.2, 113.3, 127.0,
127.6, 128.1, 128.2, 128.4, 129.4, 138.3, 138.9, 142.8. Anal. (of
a purified mixture of syn-3b /anti-3b in a 4:1 ratio) Calcd for
Found: C, 53.96; H, 4.98; N, 3.28. 3,5-trans-4a : oil;
1H NMR
(CDCl3) δ 2.18 (dt, J ) 7.8/12.7 Hz, 1H), 2.30 (dt, J ) 7.3/12.7
Hz, 1H), 3.15 (dd, J ) 8.0/9.9 Hz, 1H), 3.30 (dd, J ) 4.7/9.9
Hz, 1H), 3.27-3.34 (m, 1H), 3.53 (d, J ) 5.5 Hz, 2H), 4.01
(d, J ) 13.7 Hz, 1H), 4.12 (br dq, J ) 4.7/7.7 Hz, 1H), 4.24 (d, J
) 13.7 Hz, 1H), 4.52 (s, 2H), 7.26-7.41 (m, 10H); 13C NMR
(CDCl3) δ 8.3, 38.6, 62.7, 64.4, 71.3, 73.4, 76.6, 127.2, 127.6,
127.7, 128.2, 128.4, 129.1, 135.5, 137.9. Anal. Calcd for
C
19H22NO2I: C, 53.89; H, 5.24; N, 3.31. Found: C, 53.72; H,
5.12; N, 3.47.
2-Ben zyl-3-[(ben zyloxy)m eth yl]-5-(iod om eth yl)-4-m eth -
ylisoxa zolid in e (4b). 3,4-trans-4,5-trans-4b: oil; 1H NMR
(CDCl3) δ 1.24 (d, J ) 6.8 Hz, 3H), 2.09-2.26 (m, 1H), 2.85 (dt,
J ) 5.6/11.7 Hz, 1H), 3.28 (d, J ) 6.4 Hz, 2H), 3.59 (d, J )
5.6 Hz, 2H), 3.82 (q, J ) 6.4 Hz, 1H), 3.94 (d, J ) 14.0 Hz, 1H),
4.31 (d, J ) 14.0 Hz, 1H), 4.53 (s, 2H), 7.22-7.40 (m, 10H);
13C NMR (CDCl3) δ 8.0, 18.2, 47.2, 61.7, 71.1, 73.2, 73.3, 82.6,
127.0, 127.5, 127.6, 128.1, 128.4, 128.7, 137.8, 137.9. Anal.
Calcd for C20H24NO2I: C, 54.91; H, 5.53; N, 3.20. Found: C,
54.65; H, 5.61; N, 3.37. 3,4-trans-4,5-cis-4b: oil; 1H NMR (CDCl3)
δ 1.09 (d, J ) 7.1 Hz, 3H), 2.40-2.51 (m, 1H), 2.79-2.85 (m,
1H), 3.07 (dd, J ) 7.8/10.0 Hz, 1H), 3.18 (dd, J ) 6.2/10.0
Hz, 1H), 3.52-3.57 (m, 2H), 3.98 (d, J ) 14.0 Hz, 1H), 4.24-
4.34 (m, 1H), 4.26 (d, J ) 14.0 Hz, 1H), 4.51 (d, J ) 12.0 Hz,
1H), 4.55 (d, J ) 12.0 Hz, 1H), 7.27-7.40 (m, 10H); 13C NMR
(CDCl3) δ 1.3, 13.5, 42.3, 62.9, 71.6, 72.6, 73.4, 79.2, 127.2, 127.6,
127.7, 128.2, 128.4, 129.3, 137.4, 137.9. Anal. Calcd for
C
20H25NO2: C, 77.12; H, 8.10; N, 4.50. Found: C, 77.36; H, 8.04;
N, 4.21.
N -H y d r o x y -N -b e n zy l-1-(b e n zy lo x y )-3,3-d im e t h y l-4-
C
20H24NO2I: C, 54.91; H, 5.53; N, 3.20. Found: C, 55.12; H,
p en ten -2-a m in e (3c): Oil; 1H NMR (CDCl3) δ 1.10 (s, 3H), 1.14
(s, 3H), 2.83 (dd, J ) 3.5/6.9 Hz, 1H), 3.69 (dd, J ) 3.5/10.3 Hz,
1H), 3.95 (d, J ) 13.7 Hz, 1H), 4.15 (dd, J ) 6.9/10.3 Hz, 1H),
4.24 (d, J ) 13.7 Hz, 1H), 4.51 (br s, 1H), 4.54 (d, J ) 11.8 Hz,
1H), 4.60 (d, J ) 11.8 Hz, 1H), 4.96 (dd, J ) 1.4/10.7 Hz, 1H),
4.99 (dd, J ) 1.4/17.5 Hz, 1H), 5.98 (dd, J ) 10.7/17.5 Hz, 1H),
7.25-7.42 (m, 10H); 13C NMR (CDCl3) δ 24.4, 26.1, 40.7, 64.0,
66.6, 72.8, 73.2, 111.1, 126.9, 127.5, 127.6, 128.2, 128.4, 129.1,
138.4, 139.2, 146.8. Anal. Calcd for C21H27NO2: C, 77.49; H,
8.37; N, 4.31. Found: C, 77.71; H, 8.56; N, 4.62.
5.58; N, 3.14.
2-Ben zyl-3-[(b en zyloxy)m et h yl]-5-(iod om et h yl)-4,4-d i-
m eth ylisoxa zolid in e (4c). 3,5-trans-4c: oil; 1H NMR (CDCl3)
δ 1.13 (s, 6H), 3.06 (d, J ) 6.6 Hz, 1H), 3.34 (dd, J ) 6.6/11.2
Hz, 1H), 3.65 (d, J ) 15.3 Hz, 1H), 3.75 (d, J ) 11.2 Hz, 1H),
3.88 (dd, J ) 4.4/11.0 Hz, 1H), 4.13 (t, J ) 11.0 Hz, 1H), 4.22
(dd, J ) 4.4/11.0 Hz, 1H), 4.26 (d, J ) 15.3 Hz, 1H), 4.46 (d, J
) 11.8 Hz, 1H), 4.51 (d, J ) 11.8 Hz, 1H), 7.21-7.38 (m, 10H);
13C NMR (CDCl3) δ 27.7, 37.5, 45.8, 59.3, 69.5, 72.6, 72.9, 73.8,
126.6, 127.6, 127.8, 127.9, 128.1, 128.5, 137.5, 139.2. Anal.
Calcd for C21H26NO2I: C, 55.86; H, 5.81; N, 3.10. Found: C,
55.73; H, 5.92; N, 3.14.
N -Me t h y l-r-(1-m e t h y l)-2-p r o p e n y lb e n ze n e m e t h a n -
a m in e (3d ). The product was obtained as a mixture of the two
syn/anti isomers having the same Rf on silica gel. The following
spectroscopic data were drawn from the enriched mixtures
obtained in entries 1 and 3 of Table 2. syn-3d : 1H NMR (CDCl3)
δ 0.95 (d, J ) 6.9 Hz, 3H), 2.53 (s, 3H), 3.00-3.08 (m, 1H), 3.41
(d, J ) 2.2 Hz, 1H), 4.95-5.00 (m, 2H), 5.75-5.87 (m, 1H), 7.26-
7.35 (m, 5H); 13C NMR (CDCl3) δ 17.6, 39.2, 46.3, 78.8, 114.6,
127.4, 127.8, 128.5, 129.6, 137.5, 140.4. anti-3d : 1H NMR
(CDCl3) δ 0.85 (d, J ) 6.8 Hz, 3H), 2.44 (s, 3H), 2.90-2.99 (m,
1H), 3.38 (s, 1H), 4.73 (br s, 1H), 5.05 (ddd, J ) 0.6/1.9/10.2 Hz,
1H), 5.13 (ddd, J ) 0.9/1.9/17.1, 1H), 5.87 (ddd, J ) 8.6/10.2/
17.1, 1H), 7.25-7.40 (m, 5H); 13C NMR (CDCl3) δ 16.9, 40.7, 45.4,
77.9, 113.5, 127.4, 127.8, 128.4, 128.7, 137.0, 143.2. Anal. (of a
purified mixture of syn-3d /anti-3d in a 7:3 ratio) Calcd for
5-(Iod om eth yl)-2,4-d im eth yl-3-p h en ylisoxa zolid in e (4d ).
3,4-cis-4,5-trans-4d : oil; 1H NMR (CDCl3) δ 0.76 (d, J ) 7.3 Hz,
3H), 2.53 (ddq, J ) 5.7/7.3/8.3 Hz, 1H), 2.68 (s, 3H), 3.33 (dd, J
) 5.7/10.4 Hz, 1H), 3.38 (dd, J ) 5.7/10.4 Hz, 1H), 3.72 (q, J )
5.7 Hz, 1H), 3.77 (d, J ) 8.3 Hz, 1H), 7.20-7.40 (m, 5H); 13C
NMR (CDCl3) δ 7.2, 15.8, 44.0, 48.1, 76.2, 83.7, 127.5, 128.2,
128.3, 136.8. Anal. Calcd for C12H16NOI: C, 45.42; H, 5.09; N,
4.42. Found: C, 45.38; H, 5.24; N, 4.46. 3,4-trans-4,5-trans-
1
4d : oil; H NMR (CDCl3) δ 1.18 (d, J ) 6.8 Hz, 3H), 2.38 (ddq,
J ) 5.7/6.8/9.3 Hz, 1H), 2.55 (s, 3H), 3.10 (d, J ) 9.3 Hz, 1H),
3.41 (dd, J ) 7.7/9.7 Hz, 1H), 3.48 (dd, J ) 5.7/9.7 Hz, 1H), 3.96
(dt, J ) 5.7/7.7 Hz, 1H), 7.28-7.40 (m, 5H); 13C NMR (CDCl3) δ
9.3, 16.9, 43.3, 54.1, 82.4, 83.1, 127.8, 128.1, 128.7, 137.5. Anal.
C
12H17NO: C, 75.34; H, 8.96; N, 7.33. Found: C, 75.38; H, 8.84;
N, 7.52.
2-Ben zyl-3-[(ben zyloxy)m eth yl]-5-(iod om eth yl)isoxa zo-
(11) All the O-silylated hydroxylamines, contrary to starting hy-
droxylamines, are easily analyzed by GC-MS and show the charac-
teristic fragment due to the loss of the allylic moiety from the molecular
ion.
lid in e (4a ). Gen er a l P r oced u r e for t h e Iod ocycliza t ion
Rea ction . Imidazole (190 mg, 2.8 mmol) and TMSCl (0.36 mL,
2.8 mmol) were added to a solution of 3a (420 mg, 1.4 mmol) in